Combo blood pressure drug approved

06/21/2007 | CNNMoney/Fortune

The FDA approved the Novartis blood pressure drug Exforge, a combination drug using Diovan and Pfizer's Norvasc, both currently big sellers for the companies. Approval of the new drug is seen as an opportunity for Pfizer to extend sales of Norvasc, which loses patent protection this year, as well as a boost for Novartis.

View Full Article in:

CNNMoney/Fortune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC